Capital RX – Trademark Portfolio

Entity Type: 03

Capital RX holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include JUDI, CAPITAL RX, and CLEARINGHOUSE MODEL. The owner is based in New York, NY.

New York, NY 10003

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Capital RX's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (3 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Capital RX have?

Capital RX has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Capital RX file in?

Capital RX files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Capital RX's most well-known trademarks?

Capital RX's registered trademark portfolio includes well-known marks such as JUDI, CAPITAL RX, and CLEARINGHOUSE MODEL. These are among 3 currently registered trademarks in the portfolio.

What is Capital RX's trademark registration success rate?

Capital RX has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.